TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases

Author(s): Stella Bernardi, Daniela Milani, Bruno Fabris, Paola Secchiero, Giorgio Zauli

Journal Name: Current Drug Targets

Volume 13 , Issue 9 , 2012

Become EABM
Become Reviewer


This review focuses on TNF-related apoptosis-inducing ligand (TRAIL), also called Apo2 ligand, a protein belonging to the TNF superfamily. TRAIL can be found either in its transmembrane or circulating form, and its mostly studied peripheral effect is the induction of cellular apoptosis. Here, we discuss the evidences supporting the use of TRAIL as biomarker of cardiovascular diseases as well as the evidences showing the potential beneficial therapeutic effects of TRAIL on cardiovascular diseases and diabetes.

Keywords: Cardiovascular diseases, diabetes, TRAIL, Apo2 ligand, TNF, cellular apoptosis, OPG, coronary artery disease, biomarkers, soluble protein

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 18 July, 2012
Page: [1215 - 1221]
Pages: 7
DOI: 10.2174/138945012802002357
Price: $65

Article Metrics

PDF: 21